Literature DB >> 7617674

Asymmetrical development of the dopamine system in the fetal rat as indicated by lateralized administration of SKF-38393 and SCH-23390.

E I Varlinskaya1, E S Petrov, S R Robinson, W P Smotherman.   

Abstract

The dopamine D1 agonist SKF-38393 and the D1 antagonist SCH-23390 were administered into the left or right cerebral hemisphere of the rat fetus on E21 of gestation. Intrahemispheric (IH) injection of the agonist promoted a large-magnitude increase in fetal motor behavior, which involved movements of the head, limbs, and body trunk. Although no lateral asymmetries were evident in left or right injections of the agonist, IH injection of the antagonist into the fetus's left hemisphere produced more pronounced effects on oral behavior, including mouth, lick, and facial wipe movements. Administration of SCH-23390 into the same hemisphere as SKF-38393 was effective in reversing the behavioral effects of the agonist, with left IH injections showing more immediate and complete blockade of agonist-induced behavioral activation. These data provide evidence for functional asymmetries in D1 receptors of the dopamine system in the term rat fetus.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7617674     DOI: 10.1016/0091-3057(94)00273-l

Source DB:  PubMed          Journal:  Pharmacol Biochem Behav        ISSN: 0091-3057            Impact factor:   3.533


  3 in total

1.  L-dopa reverses behavioral deficits in the Pitx3 mouse fetus.

Authors:  Gale A Kleven; Heather M Booth; Marco Voogd; April E Ronca
Journal:  Behav Neurosci       Date:  2014-08-25       Impact factor: 1.912

2.  Perinatal distress leads to lateralized medial prefrontal cortical dopamine hypofunction in adult rats.

Authors:  W G Brake; R M Sullivan; A Gratton
Journal:  J Neurosci       Date:  2000-07-15       Impact factor: 6.167

3.  Prenatal ontogeny of the dopamine-dependent neurobehavioral phenotype in Pitx3-deficient mice.

Authors:  Gale A Kleven; Priyanka Joshi; Marco Voogd; April E Ronca
Journal:  Eur J Neurosci       Date:  2013-03-13       Impact factor: 3.386

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.